Equitable Dissemination of Medical Technologies: Endorsed by UBC, January 10th 2010
Originally published on January 17, 2010 In 2007, UBC became the first university in Canada to develop a broad strategy to ensure global access to its technologies. A key component in maximizing the societal impact of UBC research, the strategy was developed by UBC’s University-Industry Liaison Office in collaboration with the UBC chapter of the […]
Disaster Relief in Haiti
Originally published on January 14, 2010 Dear Colleagues, If you would like to help children in Haiti during the recovery and rebuilding from the earthquake, please consider making a donation to the emergency fund set up by the Haitian Timoun Foundation (HTF). HTF supports partner organizations in Haiti, including orphanages, group homes, schools, a children’s […]
Call to reform Canada’s Access to Medicines Regime (CAMR)
Originally posted on January 13, 2010 59 notable Canadians from the worlds of politics, development, law, medicine and the arts, are publicly calling on parliamentarians to reform Canada’s Access to Medicines Regime (CAMR). Among those signing the letter are former Prime Minister Paul Martin, former Lieutenant Governor of Ontario James Bartleman, former UN Special Envoy […]
Let’s Talk Sustainability and Global Health (NOW! at the 2010 Student Leadership Conference)
Originally published on January 4, 2010 Reposted from www.now-org.com Join us at this panel workshop in on 9 January 2010! Global Health, Sustainability, and Leadership Come to learn more about cutting edge ideas and ways to take action in sustainability and global health. This panel discussion is presented by the UBC Neglected Global Diseases Initiative […]
HESO 449B: Increasing Access to Essential Medicines
Originally posted on November 2, 2009 The World Health Organization estimates that one third of the world lacks regular access to essential medicines, defined as those drugs and diagnostics necessary for a basic health care system. Furthermore, 10 million people die unnecessarily every year because they lack access to existing medical treatments. HESO 449B is […]
CPDD/Gates foundation lends support to UBC-developed meds
Originally published on September 29, 2009 The Consortium for Parasitic Drug Development (CPDD) has announced an initial funding of more than US$180,000 to iCo Therapeutics to assist its development of Prof. Kishor Wasan’s oral delivery of the drug Amp B. Used to treat Visceral Leishmaniasis, VL, a parasitic disease that is typically transmitted by sand […]
iCo Therapeutics Signs Collaboration Agreement with The Consortium for Parasitic Drug Development
Originally published on September 24, 2009 VANCOUVER, Canada- iCo Therapeutics Inc. (TSX-V: ICO) is pleased to announce that the company has signed a collaboration development agreement with The Consortium for Parasitic Drug Development (CPDD) for the research and development of iCo’s oral drug delivery technology for the treatment of neglected diseases such as leishmaniasis and […]
Centre for International Health: Success and Opportunities 2009
Originally posted on July 21, 2009 The landscape has changed dramatically since the University of British Columbia Senate established the Centre for International Health (CIH) in 1998. Internationalization is now one of five pillars of UBC’s Trek 2010 Vision. UBC is committed to broadening global awareness both on and off the campus through innovative […]
New Funding to Study Neglected Global Diseases
UBC Reports | Vol. 55 | No. 6 | June 4, 2009 By Brian Lin What began as a serendipitous discovery in Prof. Kishor Wasan’s lab almost a decade ago may soon help eradicate a painful and fatal disease in the developing world, thanks to an innovative partnership among university, government and industry and a […]